Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAtrato Onsite Regulatory News (ROOF)

  • This share is currently suspended. It was suspended at a price of 76.40
  • There is currently no data for ROOF

Dividend Declaration

19 Apr 2023 07:00

RNS Number : 6413W
Atrato Onsite Energy PLC
19 April 2023
 

19 April 2023

LEI: 213800IE1PPREDIIZB62

 

Atrato Onsite Energy plc

(the "Company")

 

Dividend declaration

 

Atrato Onsite Energy plc (LSE: ROOF), the investment company focusing on clean energy generation, declares an interim dividend of 1.23 pence per Ordinary Share in respect of the period from 1 January 2023 to 31 March 2023 as scheduled below:

Ex-dividend date

27 April 2023

Record date

28 April 2023

Payment date

26 May 2023

 

The Company is targeting an annualised dividend of five pence per Ordinary Share for its second financial year as set out at IPO.

 

 

ENQUIRIES

 

Atrato Partners

Gurpreet Gujral

Christopher Fearon

 

+44 (0)77 959 75560

Berenberg

Gillian Martin

Ben Wright

Dan Gee-Summons

 

+44 (0)20 3207 7800

Kaso Legg Communications

Charles Gorman

Millie Steyn

 

atrato@kl-communications.com

+44 (0)20 3995 6673

+44 (0)20 3995 6671

 

 

Notes to Editors

Atrato Onsite Energy plc (LSE: ROOF) is an investment company focused on clean energy generation, providing new renewable energy capacity with 100% carbon traceability to industrial and commercial counterparties. The Company focuses on UK commercial solar, helping its corporate clients achieve net zero and reduce their energy bills. It raised £150 million in a significantly oversubscribed IPO in November 2021. Atrato Onsite Energy plc provides investors with attractive capital growth and secure, index-linked income, targeting a 5% dividend yield and a total shareholder return of 8 - 10%(1). Its shares were admitted to trading on the premium segment of the Main Market of the London Stock Exchange on 23 November 2021. Atrato Partners Limited is the Company's investment adviser.

 

Further information is available on the Company's website, www.atratoroof.com.

 

(1) The target dividend set out above is a target and is not a profit forecast. There can be no assurance that this target can or will be met. This target has been developed based upon assumptions with respect to future business decisions and conditions that are subject to change, including the Company's execution of its investment objective and strategies, as well as growth in the sector and markets in which the Company operates. As a result, the Company's actual results may vary from the targets set out above and those variations may be material. The target dividend yield reflects the IPO price of 100 pence per Ordinary Share.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVIPMITMTJBBTJ
Date   Source Headline
14th Sep 202310:42 amRNSHolding(s) in Company
13th Sep 20237:00 amRNSAcquisition of 34MW Operational Rooftop portfolio
4th Sep 20237:00 amRNSNew Revolving Credit Facility
27th Jul 202312:31 pmRNSDirector Declaration
27th Jul 20237:00 amRNSDividend Declaration
12th Jul 20237:00 amRNSProject London Road update – PPA signed
28th Jun 20237:00 amRNSProject Skeeby update – PPA signed
23rd Jun 20231:17 pmRNSDirectorate Change
13th Jun 20235:37 pmRNSDirector/PDMR Shareholding
13th Jun 20237:00 amRNSInterim results to 31 March 2023
8th Jun 20234:55 pmRNSHolding(s) in Company
7th Jun 202310:00 amRNSInvestor presentation via Investor Meet Company
25th May 20237:00 amRNSOperational update and unaudited Net Asset Value
15th May 20237:00 amRNSNotice of Interim Results
21st Apr 20239:45 amRNSChange of Registered Office
19th Apr 20237:00 amRNSDividend Declaration
14th Apr 20237:00 amRNSAcquisition of 50MW North Yorkshire solar project
12th Apr 20237:00 amRNSAppointment of Director
5th Apr 20233:18 pmRNSHolding(s) in Company
31st Mar 202311:41 amRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSDirector/PDMR Shareholding
30th Mar 20237:00 amRNSDirector/PDMR Shareholding
30th Mar 20237:00 amRNSDirector/PDMR Shareholding
24th Mar 202310:40 amRNSInvestment of £29 million into two solar projects
10th Mar 20233:07 pmRNSResult of AGM
1st Mar 202312:01 pmRNSHolding(s) in Company
17th Feb 20233:59 pmRNSUpdate on Corporate Brokers
16th Feb 20237:00 amRNSInvestment Update and New Framework Agreement
9th Feb 20231:53 pmRNSHolding(s) in Company
2nd Feb 20237:00 amRNSNotice of AGM
26th Jan 20237:00 amRNSDividend Declaration
24th Jan 20237:00 amRNSDirector/PDMR Shareholding
5th Jan 20234:56 pmRNSHolding(s) in Company
23rd Dec 20229:09 amRNSAppointment of Joint Corporate Broker
1st Dec 20225:15 pmRNSHolding(s) in Company
1st Dec 20227:00 amRNSDirector/PDMR Shareholding
30th Nov 20227:00 amRNSDirector/PDMR Shareholding
30th Nov 20227:00 amRNSDirector/PDMR Shareholding
29th Nov 20227:00 amRNSFinal Results for the period ended 30 Sept 2022
24th Nov 202212:05 pmRNSHolding(s) in Company
22nd Nov 20227:00 amRNSNo impact from Electricity Generator Levy
16th Nov 20227:00 amRNSNotice of Results
11th Nov 20227:00 amRNSDividend Declaration
31st Oct 20227:00 amRNSNet Asset Value - 30 September 2022
10th Oct 20223:43 pmRNSHolding(s) in Company
10th Oct 20223:11 pmRNSHolding(s) in Company
6th Oct 20227:16 amRNSVale of Mowbray Uodate
3rd Oct 20222:33 pmRNSDirector/PDMR Shareholding
16th Sep 20225:58 pmRNSDirector/PDMR Shareholding
7th Sep 20227:00 amRNSTransaction Update - Sonne Solar & Recipharm

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.